chr20-34710207-C-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_021202.3(TP53INP2):c.563C>A(p.Ala188Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000152 in 1,318,372 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_021202.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
TP53INP2 | NM_021202.3 | c.563C>A | p.Ala188Glu | missense_variant | 5/5 | ENST00000374810.8 | |
TP53INP2 | NM_001329429.2 | c.563C>A | p.Ala188Glu | missense_variant | 5/5 | ||
TP53INP2 | NM_001329430.2 | c.563C>A | p.Ala188Glu | missense_variant | 4/4 | ||
TP53INP2 | NM_001329431.2 | c.563C>A | p.Ala188Glu | missense_variant | 5/5 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
TP53INP2 | ENST00000374810.8 | c.563C>A | p.Ala188Glu | missense_variant | 5/5 | 1 | NM_021202.3 | P1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 0.00000152 AC: 2AN: 1318372Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 652836
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 04, 2024 | The c.563C>A (p.A188E) alteration is located in exon 5 (coding exon 3) of the TP53INP2 gene. This alteration results from a C to A substitution at nucleotide position 563, causing the alanine (A) at amino acid position 188 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at